FDA Weighs Clinician-Style Tests for Generative AI Medical Devices - PYMNTS.com
Reported by PYMNTS.com · all stories from pymnts.com
Editorial digest
The Food and Drug Administration is evaluating the use of clinician-like testing methods for generative artificial intelligence medical devices, to ensure their practical effectiveness.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at PYMNTS.com →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom8/20/2026
FDA weighs regulatory approach for genAI medical devices - MobiHealthNews
The FDA is deliberating its regulatory strategy for generative AI medical devices.
- Trusted health newsroom9/3/2026
STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized
FDA pilot program allows generative AI devices to reach patients pre-authorization.
- Trusted health newsroom8/18/2026
FDA seeks feedback on potential regulatory approaches for generative AI-enabled medical devices | AHA News - American Hospital Association
The FDA seeks input on regulating generative AI for medical devices.
- Trusted health newsroom8/4/2026
STAT+: Are AI scribes medical devices? U.K. regulator weighs in
The U.K. regulator is evaluating AI scribes as medical devices.
- Reputable trade press8/20/2026
FDA considers ‘competency-based’ evaluations for GenAI-enabled medical devices - MassDevice
The FDA is considering 'competency-based' evaluations for generative AI medical devices.
- Reputable trade press8/19/2026
Nearly All FDA-Cleared AI Medical Devices Lack Evidence of Patient Benefit - Inside Precision Medicine
Most FDA-approved AI medical devices lack strong evidence of direct patient benefit.